Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Michaël Grynberg, Claire Murphy, Carole Doré, Laurence Fresneau, Ségolène Paillet, Nicoleta Petrica, Frédérique Maurel & Harinala Ravonimbola. (2019) A cost-effectiveness analysis comparing the originator follitropin alfa to its biosimilars in patients undergoing a medically assisted reproduction program from a French perspective. Journal of Medical Economics 22:1, pages 108-115.
Read now
Read now
Jaro Wex & Ahmed M Abou-Setta. (2013) Economic evaluation of highly purified human menopausal gonadotropin versus recombinant human follicle-stimulating hormone in fresh and frozen in vitro fertilization/intracytoplasmic sperm-injection cycles in Sweden. ClinicoEconomics and Outcomes Research 5, pages 381-397.
Read now
Read now
Martin Keltz, May-Tal Sauerbrun-Cutler & Andrzej Breborowicz. (2013) Managing poor responders in IVF. Expert Review of Obstetrics & Gynecology 8:2, pages 121-134.
Read now
Read now
Hong Ye, Guoning Huang, Li Pei, Pinghong Zeng & Xiu Luo. (2012) Outcome of in vitro fertilization following stimulation with highly purified hMG or recombinant FSH in downregulated women of advanced reproductive age: a prospective, randomized and controlled trial. Gynecological Endocrinology 28:7, pages 540-544.
Read now
Read now
Colin M Howles, Diego Ezcurra & Roy Homburg. (2012) Ovarian stimulation protocols in assisted reproductive technology: an update. Expert Review of Endocrinology & Metabolism 7:3, pages 319-330.
Read now
Read now
Articles from other publishers (26)
Hassan Ali El Maghraby, Abdel Fattah Mohamed Agameya, Manal Shafik Swelam, Nermeen Ahmed ElDabah & Ola Youssef Ahmed. (2022) Consecutive versus concomitant follicle-stimulating hormone and highly purified human menopausal gonadotropin: A milder response but better quality. Clinical and Experimental Reproductive Medicine 49:2, pages 135-141.
Crossref
Crossref
Ioannis E. Messinis, Christina I. Messini, George Anifandis & Alexandros Daponte. 2022. Ovarian Stimulation. Ovarian Stimulation
199
207
.
Nicole E. Cieri- Hutcherson, John Brock Harris, Lamis R. Karaoui, Lauren Lakdawala, Nicole M. Lodise, Rebecca H. Stone & Veronica Vernon. (2020) Infertility Management and Pharmacotherapy: What Every Pharmacist Should Know. Journal of Pharmacy Practice 34:4, pages 635-647.
Crossref
Crossref
E. Bosch, J. J. Espinós, F. Fabregues, J. Fontes, J. García-Velasco, J. Llácer, A. Requena, M. A. Checa & J. Bellver. (2020) ALWAYS ICSI? A SWOT analysis. Journal of Assisted Reproduction and Genetics 37:9, pages 2081-2092.
Crossref
Crossref
Zhisong Ji, Xiaozhen Quan, Yanli Lan, Meng Zhao, Xiaolong Tian & Xuezhou Yang. (2020) Gonadotropin versus Follicle-Stimulating Hormone for Ovarian Response in Patients Undergoing in vitro Fertilization: A Retrospective Cohort Comparison. Current Therapeutic Research 92, pages 100572.
Crossref
Crossref
Raoul Orvieto. (2019) HMG versus recombinant FSH plus recombinant LH in ovarian stimulation for IVF: does the source of LH preparation matter?. Reproductive BioMedicine Online 39:6, pages 1001-1006.
Crossref
Crossref
E M Bordewijk, F Mol, F van der Veen & M Van Wely. (2019) Required amount of rFSH, HP-hMG and HP-FSH to reach a live birth: a systematic review and meta-analysis. Human Reproduction Open 2019:3.
Crossref
Crossref
Fatemeh Taheri, Arezoo Alemzadeh Mehrizi, Mohammad Ali Khalili & Iman Halvaei. (2018) The influence of ovarian hyperstimulation drugs on morphometry and morphology of human oocytes in ICSI program. Taiwanese Journal of Obstetrics and Gynecology 57:2, pages 205-210.
Crossref
Crossref
Shruti Parikh & Christophe Blockeel. 2018. Preventing Age Related Fertility Loss. Preventing Age Related Fertility Loss
125
139
.
Xiangqin Zheng, Danmei Lin, Yulong Zhang, Yuan Lin, Jianrong Song, Suyu Li & Yan Sun. (2017) Inositol supplement improves clinical pregnancy rate in infertile women undergoing ovulation induction for ICSI or IVF-ET. Medicine 96:49, pages e8842.
Crossref
Crossref
Sudha Prasad & Mona Dahiya. 2015. Principles and Practice of Controlled Ovarian Stimulation in ART. Principles and Practice of Controlled Ovarian Stimulation in ART
83
92
.
Rogério de Barros Ferreira Leão & Sandro C. Esteves. 2015. Unexplained Infertility. Unexplained Infertility
293
322
.
Rogério de Barros F. Leão & Sandro C. Esteves. (2014) Gonadotropin therapy in assisted reproduction: an evolutionary perspective from biologics to biotech. Clinics 69:4, pages 279-293.
Crossref
Crossref
David Reichman & Zev Rosenwaks. 2014. Human Fertility. Human Fertility
289
304
.
Carriann Smith, Maureen Grimm & Megan Schwegel. (2012) Treatment of infertility in women. Journal of the American Pharmacists Association 52:4, pages e27-e42.
Crossref
Crossref
Zeev Shoham & Colin M. Howles. 2012. Textbook of Assisted Reproductive Techniques, Volume Two: Clinical Perspectives. Textbook of Assisted Reproductive Techniques, Volume Two: Clinical Perspectives
51
74
.
Carriann Smith, Maureen Grimm & Megan Schwegel. (2012) Treatment of infertility in women. Pharmacy Today 18:6, pages 61-76.
Crossref
Crossref
Á. Murber, P. Fancsovits, Nóra Ledó, M. Szakács, J. Rigó & J. Urbancsek. (2011) Impact of highly purified versus recombinant follicle stimulating hormone on oocyte quality and embryo development in intracytoplasmic sperm injection cycles. Acta Biologica Hungarica 62:3, pages 255-264.
Crossref
Crossref
A. P. Yates, O. Rustamov, S. A. Roberts, H. Y. N. Lim, P. W. Pemberton, A. Smith & L. G. Nardo. (2011) Anti-Mullerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF. Human Reproduction 26:9, pages 2353-2362.
Crossref
Crossref
Madelon van Wely, Irene Kwan, Anna L Burt, Jane Thomas, Andy Vail, Fulco Van der Veen & Hesham G Al-Inany. (2011) Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Els Groeneveld, Ilse J.E. Kouijzer, Adriana J. Timmermans, Roel Schats & Peter G.A. Hompes. (2011) Effectiveness of highly purified human menopausal gonadotropin in intra-uterine insemination. European Journal of Obstetrics & Gynecology and Reproductive Biology 154:2, pages 182-186.
Crossref
Crossref
Ernesto Bosch. 2011. Ovarian Stimulation. Ovarian Stimulation
67
76
.
. 2011. Ovarian Stimulation. Ovarian Stimulation
42
76
.
Geoffrey H Trew, Adam P Brown, Samantha Gillard, Stuart Blackmore, Christine Clewlow, Paul O'Donohoe & Radoslaw Wasiak. (2010) In vitro fertilisation with recombinant follicle stimulating hormone requires less IU usage compared with highly purified human menopausal gonadotrophin: results from a European retrospective observational chart review. Reproductive Biology and Endocrinology 8:1.
Crossref
Crossref
Philippe Lehert, Joan C Schertz & Diego Ezcurra. (2010) Recombinant human follicle-stimulating hormone produces more oocytes with a lower total dose per cycle in assisted reproductive technologies compared with highly purified human menopausal gonadotrophin: a meta-analysis. Reproductive Biology and Endocrinology 8:1.
Crossref
Crossref
E. Bosch, E. Labarta, J. Crespo, C. Simón, J. Remohí, J. Jenkins & A. Pellicer. (2010) Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles. Human Reproduction 25:8, pages 2092-2100.
Crossref
Crossref